Einstein, David J.
Sonpavde, Guru
Article History
First Online: 11 February 2019
Compliance with Ethical Standards
:
: David J. Einstein has received research funding (paid to Beth Israel Deaconess Medical Center, Boston, MA) for clinical trials from Bristol-Myers Squibb and TrovaGene.Guru Sonpavde has received research funding (paid to Dana-Farber Cancer Institute, Boston, MA) for clinical trials from Boehringer Ingelheim, Bayer, Onyx-Amgen, Pfizer, Merck, Sanofi, Janssen, and Celgene; has received compensation for service as a consultant from Pfizer, Genentech, Novartis, Merck, Sanofi, Agensys/Astellas, AstraZeneca, Biotheranostics, Exelixis, Bristol-Myers Squibb, Janssen, Amgen, Eisai, and the National Comprehensive Cancer Network; has received CME lecture fees from Clinical Care Options; has received speaker’s honoraria from Physicians Education Resource, OncLive, and Research to Practice; has been a member of the data safety monitoring board of a trial funded by AstraZeneca; and has received honoraria from UpToDate for authorship of an education chapter/review.
: This article does not contain any studies with human or animal subjects performed by any of the authors.